Becton Dickinson (XSWX:BDX) 3-Month Share Buyback Ratio: 3.23% (As of Mar. 2026 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:BDX Becton Dickinson & Co XSWX:BDX
79 GF Score
Price CHF133.58
GF Value CHF151.69
! 4 Warning Signs
View Full Analysis

What is Becton Dickinson 3-Month Share Buyback Ratio?

Becton Dickinson XSWX:BDX -2.72% 79 3-Month Share Buyback Ratio is 3.23 as of Mar. 2026. GuruFocus rates XSWX:BDX with a GF Score™ of 79/100 and a GF Value™ of CHF151.69. The stock has 4 warning signs investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Becton Dickinson's current 3-Month Share Buyback Ratio was 3.23%.


Becton Dickinson  (XSWX:BDX) 3-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.


Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.


Becton Dickinson 3-Month Share Buyback Ratio Related Terms


XSWX:BDX vs MDLN, RMD, WST: 3-Month Share Buyback Ratio Comparison

For the Medical Instruments & Supplies subindustry, Becton Dickinson's 3-Month Share Buyback Ratio, along with its competitors' market caps and 3-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Becton Dickinson 3-Month Share Buyback Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's 3-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Becton Dickinson's 3-Month Share Buyback Ratio falls into.


XSWX:BDX
79GF Score
Becton Dickinson & Co XSWX:BDX
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Becton Dickinson 3-Month Share Buyback Ratio Calculation

Becton Dickinson's 3-Month Share Buyback Ratio for the quarter that ended in Mar. 2026 is calculated as

3-Month Share Buyback Ratio=(Shares Outstanding (EOP) (Dec. 2025 ) - Shares Outstanding (EOP) (Mar. 2026 )) / Shares Outstanding (EOP) (Dec. 2025 )
=(284.742 - 275.540) / 284.742
=3.23%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a 3-Month Share Buyback Ratio of 3.23 mean?
Becton Dickinson (XSWX:BDX) has a 3-Month Share Buyback Ratio of 3.23 as of Mar. 2026. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Becton Dickinson and its competitors.
Is Becton Dickinson's 3-Month Share Buyback Ratio too high?
Becton Dickinson's current 3-Month Share Buyback Ratio is 3.23. Overall, Becton Dickinson has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's 3-Month Share Buyback Ratio compare to MDLN and RMD?
Becton Dickinson's 3-Month Share Buyback Ratio of 3.23 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Medical Devices & Instruments company?
A good 3-Month Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Becton Dickinson and its competitors. Becton Dickinson's current 3-Month Share Buyback Ratio is 3.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Becton Dickinson (XSWX:BDX) has a current 3-Month Share Buyback Ratio of 3.23. The stock's GF Value™ is CHF151.69, compared to a current price of CHF133.58 — trading 11.9% below its estimated fair value. The current 3-Month Share Buyback Ratio is 3.23. Becton Dickinson's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For Becton Dickinson (XSWX:BDX), the current 3-Month Share Buyback Ratio is 3.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Becton Dickinson (XSWX:BDX) Overvalued in 2026?

Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued. The current stock price of CHF133.58 is trading 11.9% below its estimated GF Value™ of CHF151.69.

Key valuation signals for XSWX:BDX:

  • 3-Month Share Buyback Ratio: 3.23
  • GF Value™: CHF151.69 vs. price of CHF133.58 (11.9% below fair value)
  • GF Score™: 79/100 with 4 warning signs

No single metric tells the full story. See the XSWX:BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Becton Dickinson Business Description

Address 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
79GF Score

Get the complete analysis for XSWX:BDX

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF133.58
Price
CHF151.69
GF Value